Compare IPHA & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPHA | LOVE |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | France | United States |
| Employees | 163 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.5M | 193.2M |
| IPO Year | N/A | 2018 |
| Metric | IPHA | LOVE |
|---|---|---|
| Price | $1.76 | $15.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $5.75 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 134.2K | 110.0K |
| Earning Date | 03-26-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.28 |
| Revenue | N/A | ★ $697,115,000.00 |
| Revenue This Year | $180.36 | $4.63 |
| Revenue Next Year | N/A | $6.40 |
| P/E Ratio | ★ N/A | $57.75 |
| Revenue Growth | N/A | ★ 2.42 |
| 52 Week Low | $1.18 | $10.33 |
| 52 Week High | $2.63 | $21.06 |
| Indicator | IPHA | LOVE |
|---|---|---|
| Relative Strength Index (RSI) | 54.22 | 47.76 |
| Support Level | $1.72 | $14.04 |
| Resistance Level | $2.32 | $16.25 |
| Average True Range (ATR) | 0.20 | 0.62 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 40.00 | 35.81 |
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.